Results 231 to 240 of about 254,297 (340)

Preregistration of high‐quality protocols in pharmacoepidemiology research

JCPP Advances, EarlyView.
Abstract Pharmacoepidemiology studies are an important complement to Randomized Clinical trials, but such studies face several challenges, such as confounding and selective reporting. How to best address confounding has been discussed in detail for many years.
Henrik Larsson, Zhang Chang, Kenneth K. C. Man   +2 more
wiley   +1 more source

Selective Visual Attention in ADHD: A Narrative Review. [PDF]

Curr Neurol Neurosci Rep
Klein JL, Allen HA, Clibbens J, Cook A, Amanatidou V, Mavritsaki E.   +5 more
europepmc   +1 more source

Self-Monitoring Behaviors in Students with Attention Deficit Hyperactivity Disorder [PDF]

, 2016
Mas, Ana
core  

The efficacy of neurofeedback in the management of children with attention deficit/hyperactivity disorder [PDF]

, 2001
Lola Baydala, Erik Wikman
openalex   +1 more source

A comprehensive longitudinal analysis of changes during Attention Deficit Hyperactive Disorder pharmacological treatments: Relationships between clinical measures, QbCheck and Conners CPT‐II

JCPP Advances, EarlyView.
Abstract Background This study aims to evaluate the clinical value of using QbCheck in routine Attention Deficit Hyperactive Disorder (ADHD) clinics by investigating longitudinal inter‐domain relationships between objective neurocognitive outcomes of QbCheck and subjective clinical outcomes: ADHD core symptoms, impairment and quality of life (QoL ...
Seungjae Lee, Renee Testa, Beth Johnson, David Coghill   +3 more
wiley   +1 more source

Comparing Obstetrical Outcomes Between Attention Deficit Hyperactivity Disorder and Attention Deficit Disorder: A Population-Based Studys. [PDF]

J Clin Med
Amikam U, Badeghiesh A, Baghlaf H, Brown R, Dahan MH.   +4 more
europepmc   +1 more source

ASSESSMENT OF IMPULSIVITY AND THE DEVELOPMENT OF SELF‐CONTROL IN STUDENTS WITH ATTENTION DEFICIT HYPERACTIVITY DISORDER

, 2001
Nancy A. Neef, David F. Bicard, Sayaka Endo   +2 more
openalex   +1 more source

Systematic review: Safety and efficacy of atomoxetine in children and adolescents with autism spectrum disorder

JCPP Advances, EarlyView.
This systematic review aimed to assess the current evidence on the efficacy and safety of Atomoxetine in common clinical symptoms of autism spectrum disorder (ASD) for children and adolescents. With limited studies available, there is a need for more high‐power studies for the use of Atomoxetine in children and adolescents with autism spectrum disorder.
Nihit Gupta, Daniel Boyes, Hunter Hanlon‐Taylor, Mayank Gupta   +3 more
wiley   +1 more source

Gaming disorder with attention-deficit/hyperactivity disorder and social anxiety disorder comorbidities: A cross-sectional analysis of differences. [PDF]

Medicine (Baltimore)
İçen S, Taş Torun Y, Işik Y.
europepmc   +1 more source

Genetic and environmental influences on sleep quality, ability to settle, and crying duration in 2‐ and 5‐month‐old infants: A longitudinal twin study

JCPP Advances, EarlyView.
This study found that genetic factors largely influence crying duration and settle ability in infancy, while shared environmental factors primarily affect the number of night wakeups. Etiological influences tended to change from 2 to 5 months, reflecting a highly plastic period in infant brain development and in child‐environment interactions. Abstract
Charlotte Viktorsson, Ashraf Yahia, Mark J. Taylor, Angelica Ronald, Kristiina Tammimies, Terje Falck‐Ytter   +5 more
wiley   +1 more source